Enhancement of tongue carcinogenesis in Hras128 transgenic rats treated with 4-nitroquinoline 1-oxide

  • Authors:
    • Kuniko Naoi
    • Nao Sunagawa
    • Ichiro Yoshida
    • Takamitsu Morioka
    • Makoto Nakashima
    • Masashi Ishihara
    • Katsumi Fukamachi
    • Yoshinori Itoh
    • Hiroyuki Tsuda
    • Naoki Yoshimi
    • Masumi Suzui
  • View Affiliations

  • Published online on: February 1, 2010     https://doi.org/10.3892/or_00000641
  • Pages: 337-344
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Transgenic rats carrying human c-Ha-ras proto-oncogene (Hras128 rats) have been shown to be highly susceptible to induction of tumors. We have found an early induction of tongue tumors in Hras128 rats treated with 4-nitroquinoline 1-oxide (4NQO). 4NQO was administered to the Hras128 and wild-type Sprague-Dawley (SD) rats for 4 and 8 weeks, respectively. The experiment was terminated at 14 (Hras128 rats) and 28 (SD rats) weeks. Either during or after treatment with 4NQO, dysplastic hyperplasia, papilloma and squamous cell carcinoma were found on the tongue of both Hras128 and wild-type rats, with a higher incidence and multiplicity in Hras128 rats. Treatment of the Hras128 rats with 4NQO significantly increased cell proliferation in the tumor compared to the control rats. In the tongue tumors of the Hras128 rats, there was a significant increase in the mRNA expression levels of cyclin D1 and COX2. To examine whether this experimental system is useful for screening of the candidate agents for cancer preventive effect, nimesulide, a selective COX2 inhibitor, was tested in the present model. Nimesulide significantly decreased total multiplicity of tongue lesions compared to the control rats. Treatment of Hras128 rats with nimesulide caused a significant decrease in the levels of mRNA expression of cyclin D1 and COX2 in the tumor. Therefore, the current 4NQO-induced Hras128 rat tongue carcinogenesis model provides a simple and rapid system for investigating carcinogenesis process and evaluating the effect of possible cancer preventive agents for human tongue cancer.

Related Articles

Journal Cover

February 2010
Volume 23 Issue 2

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Naoi K, Sunagawa N, Yoshida I, Morioka T, Nakashima M, Ishihara M, Fukamachi K, Itoh Y, Tsuda H, Yoshimi N, Yoshimi N, et al: Enhancement of tongue carcinogenesis in Hras128 transgenic rats treated with 4-nitroquinoline 1-oxide. Oncol Rep 23: 337-344, 2010
APA
Naoi, K., Sunagawa, N., Yoshida, I., Morioka, T., Nakashima, M., Ishihara, M. ... Suzui, M. (2010). Enhancement of tongue carcinogenesis in Hras128 transgenic rats treated with 4-nitroquinoline 1-oxide. Oncology Reports, 23, 337-344. https://doi.org/10.3892/or_00000641
MLA
Naoi, K., Sunagawa, N., Yoshida, I., Morioka, T., Nakashima, M., Ishihara, M., Fukamachi, K., Itoh, Y., Tsuda, H., Yoshimi, N., Suzui, M."Enhancement of tongue carcinogenesis in Hras128 transgenic rats treated with 4-nitroquinoline 1-oxide". Oncology Reports 23.2 (2010): 337-344.
Chicago
Naoi, K., Sunagawa, N., Yoshida, I., Morioka, T., Nakashima, M., Ishihara, M., Fukamachi, K., Itoh, Y., Tsuda, H., Yoshimi, N., Suzui, M."Enhancement of tongue carcinogenesis in Hras128 transgenic rats treated with 4-nitroquinoline 1-oxide". Oncology Reports 23, no. 2 (2010): 337-344. https://doi.org/10.3892/or_00000641